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Abstract
The pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had overwhelmed the
healthcare system worldwide with multiple ethical dilemmas. Several tools have been used to assess risk factors in
these patients. One of them, the Clinical Frailty scale, has shown good correlation between the patient functional
status and hospital stay with overall mortality. We present a case were the Clinical Frailty Scale was used to assess
patient management and goals of care.
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Introduction
The severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) pandemic has overwhelmed the health
care system. In the United States, there has been an
exponential increase in the number of cases, with most
deaths in people aged 65 years or older (Le Couteur
et al., 2020; Zhou et al., 2020). Different studies showed
predictors of worse outcomes and prognosis. The
Clinical Frailty scale (CFS) has shown better correlation
between a patient’s baseline functional status/frailty and
the duration of hospital stay as well as overall mortality
(Hewitt et al., 2020). We present a case where the CFS
was used to guide our clinical decision making.

Case
An 81-year-old lady with past medical history of hypertension, type 2 diabetes mellitus and obesity presented
to the emergency department due to shortness of breath
for 3 days associated with generalized body weakness,
dry cough, fever, chills, nausea, and diarrhea. She denied
any recent travel or contact with COVID-19 (Coronavirus
disease 2019) patients.
Her vital signs on admission: Heart rate: 79 beats per
minute, Respiratory rate: 25 breaths per minute with
oxygen saturation of 80% on room air, Temperature:
100.4 Fahrenheit, Blood pressure: 127/58 mmHg. On
physical exam she was tachypneic, in moderate respiratory distress, and had decrease breath sounds bilaterally.

The laboratory tests showed lymphopenia, hypokalemia, elevated International normalized ratio(INR),sedimentation rate, C reactive protein, ferritin, D-dimer, lactate dehydrogenase(LDH) and a positive SARS-COV-2
PCR, further laboratory values are presented in Table 1.
The chest x-ray showed multifocal diffuse ground glass
opacities.
The patient was transitioned to high flow nasal cannula
(HFNC) at 60 liters/min with improvement of oxygen saturation to 98%. She was started on dexamethasone 6 mg
intravenous daily, enoxaparin 80 mg subcutaneous twice a
day and potassium replacement with potassium chloride
10 mEq intravenous. A unit of convalescent plasma was
ordered but was unable to get it due to lack of it in the blood
bank. Based on her poor clinical status, the palliative care
team was consulted. Unfortunate, she did not count with an
advance directive or medical power of attorney. We talked
with the family to assess her CFS before admission. As per
patient’s daughter, the patient used a walker to ambulate
around the house and had recurrent falls in the last year.
She required help to bathe, complete housework, and for
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Table 1. Laboratory analysis.
Blood analysis
Complete blood count

Complete metabolic panel

Coagulation studies

Inflammatory markers

Molecular microbiology
Arterial blood gas

Result

White blood cell
Percent neutrophils
Percent lymphocytes
Percent monocytes
Percent eosinophils
Percent basophils
Percent immature granulocytes
Hemoglobin
Hematocrit
Mean corpuscular volume
Mean corpuscular hemoglobin
Mean corposcular hemoglobin
concentration
Platelet count
Red blood cell distribution width CV
Red blood cell distribution width SD
Sodium
Potassium
Chloride
Carbon dioxide
Creatinine
BUN
Calcium
Glucose
Anion gap
AST
ALT
Alkaline phosphatase
Albumin
Total bilirrubin
PT
INR
PTT
Sedimentation rate
C Reactive protein
Lactic acid
D-dimer
Ferritin
LDH
SARS-COV-2 PCR
pH
PO2
PCO2
HCO3
FiO2
P/F ratio

14.4
87.4
5
4.9
0
0.3
2.4
13
40.1
87.7
28.4
32.4
255
13.7
43.9
140
3.4
105
22
1
27
8.4
163
16
36
24
69
3.4
0.5
13.7
1.16
23.8
109
25.7
1.87
50,887
531.3
376
Detected
7.49
48
28
21.3
44
109

Reference range
(4.8–10.9)th/uL
(49.0–77.6)%
(11.8–40.8)%
(3.70–11.80)%
(0–4.8)%
(0–1.3)%
(0–1)%
(10.8–14.7)gm/dL
(32.2–42.9)%
(84–96)fL
(28.3–32.3)pg
(29.58–33.75)gm/dL
(146–388)th/uL
(12.20–15.80)%
(38.93–51.44)fL
(132–143)mmol/L
(3.5–5.1)mmol/L
(98–107)mmol/L
(21–31)mmol/L
(0.6–1.2)mg/dL
(7–25)mg/dL
(8.6–10.3)mg/dL
(70–113)mg/dL
(2–12)mEq/L
(13–39)IU/L
(7–52)IU/L
(34–104)IU/L
(3.7–4.9)gm/dL
(0.2–1.2)mg/dL
(10.6–13)second
(0.90–1.10)
(24–36.7)second
2–30 mm/hr
<1 mg/dL
(0.5–1.99)mmol/L
<500 ng/mL
(6–264)ng/mL
(140–271)IU/L
Not detected
7.35–7.45
(83–108)mmHg
(35–48)mmHg
(18–23)mmol/L
___
___

Note. AST = Aspartate aminotransferase; ALT = Alanine aminotransferase; PT = Prothrombin Time; INR = International normalized ratio;
PTT = Partial thromboplastin time; LDH = Lactate dehydrogenase; PO2 = Partial pressure of oxygen; PCO2 = Partial pressure of carbon
dioxide; HCO3 = Bicarbonate; FiO2 = Fraction of inspired oxygen.

meal preparation. Based on this report, we scored the
patient’s CFS of 6, indicating moderate frailty. The palliative care team discussed code status with the family
explaining prognosis in patients with poor functional status. The family decided the patient should remain full code.

The following days remdesivir and colchicine were
added to her regimen. The patient required several
days of HFNC and was not able to be weaned off oxygen. She was discharge home with oxygen and full
code status.
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Discussion
On December 2019, an outbreak started in Wuhan,
China with a novel coronavirus known as SARS-CoV-2,
which has spread worldwide, causing the COVID-19
pandemic (Zhou et al., 2020).
Several tools and risk factors have been used to
determined poor prognosis/outcomes in these patients,
like elderly age, high SOFA (sequential organ failure
assessment) score, and D-dimer greater than 1 μg/mL
(Zhou et al., 2020). Comorbidities such as cancer,
chronic kidney disease, COPD (chronic obstructive
pulmonary disease), obesity, heart failure, coronary
artery disease, Type 2 diabetes mellitus and others are
still being identify by the CDC (Centers for Disease
Control and Prevention, 2019).
The worldwide pandemic came with difficult decisions where ethical dilemmas had to be faced. For
example, in Italy, the decision for who was prioritized
for ventilation was based on the patient’s age, with the
cutoff being at age 65 (Le Couteur et al., 2020).
Fortunately, with the passage of time, other tools have
been utilized to assess who might benefit from critical
care management.
Recently, a previously known scale used in the
elderly population has gained strong support for decision making. The CFS assess the frailty/functional status of an elderly individual to predict death or need for
institutional care (Rockwood et al., 2005). In the hospital setting, it correlates with a prolonged hospital
stay and risk for a complicated course of disease (Juma
et al., 2016).
The NICE (National Institute for Health and Care
Excellence) guidelines proposed that patients with
CFS score of 5 or less are considered less frail and can
likely benefit from critical care management. Those
with CFS score of 5 or more may require critical care
advice to guide the decision about treatment as there is
uncertainty in the benefits of critical care management
(Moug et al., 2020; NICE, 2020). The CFS is an
invaluable tool to recognize patients who have an
increased mortality risk, longer hospital stays, risk of
readmission, severity of disease and identify the
patients who might benefit from a discussion about
code status(Arie, 2020; Juma et al., 2016; Leclerc
et al., 2020; Moug et al., 2020; Swiss Society of
Intensive Care Medicine, 2020).
Our patient showed CFS score of 6, categorized as
moderately frail. Based on this score, we had a discussion with the patient and her family about goals of care
and explained pros and cons about further critical care
management. The patient remained hospitalized for
13 days, which correlates with longer hospital stay in
patients with CFS:5-9, with also increase mortality
compared to those who were not frail (Hewitt et al.,
2020). Furthermore, patients with higher CFS score
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have higher readmission rate compared with its peers
not frail (Juma et al., 2016).
Another main discussion in this pandemic is the code
status. Initially, the patient was unstable and unable to
communicate her wishes. In addition, she did not have
an advance directive, medical power of attorney and the
family never discussed code status before. In this patient,
like other patients in the Latino population, several factors affect the discussion of code status, they include
religious beliefs, cultural ideas, ethnicity, and language
barriers (Shen et al., 2016). In the city of McAllen,
85.3% of the population is Latino (U.S. Census Bureau,
2019), which contributes to disparities seen in end of life
care planning (Shen et al., 2016). This pandemic showed
us that one of the main priorities is to discuss goals of
care, mostly with a life-threatening illness in frail adults
(Curtis et al., 2020).

Conclusion
Multiple ethical dilemmas came up with this pandemic, where more tools are required to make crucial
decisions for patients’ life. The CFS is a tool to guide
the clinician about the benefit or not of more aggressive measures in COVID-19 patients. Further studies
and education need to be done in the Latino community to improve a better understanding of goals of care
and discussion about code status in frail adults in
which due to multiple factors this topic is often glossed
over.
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